GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

Show other versions (1)

Detalles Bibliográficos
Main Authors:	Reinhardt, K, Kate, A, Bohmer, K, Vyas, P, Dirk, R
Formato:	Conference item
Publicado:	2010

Títulos similares

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
por: Reinhardt, K, et al.
Publicado: (2010)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
por: Alford, K, et al.
Publicado: (2011)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
por: Maroz, A, et al.
Publicado: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
por: Maroz, A, et al.
Publicado: (2014)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
por: Garnett, C, et al.
Publicado: (2019)

Myeloid pre-leukemia and leukemia of Down syndrome
por: Cruz Hernandez, D, et al.
Publicado: (2020)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
por: Hasle, H, et al.
Publicado: (2008)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
por: Hellebostad, M, et al.
Publicado: (2005)

GATA2 mutations and overexpression in pediatric acute myeloid leukemia
por: Zhenzhen Yang, et al.
Publicado: (2019-08-01)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
por: Vyas, P, et al.
Publicado: (2008)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
por: Cruz Hernandez, D, et al.
Publicado: (2020)

Acute leukemias in children with Down syndrome.
por: Zwaan, C, et al.
Publicado: (2010)

Acute leukemias in children with Down syndrome.
por: Zwaan, M, et al.
Publicado: (2008)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
por: Norton, A, et al.
Publicado: (2007)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
por: Labuhn, M, et al.
Publicado: (2019)

Natural history of GATA-1 mutations in Down syndrome.
por: Ahmed, M, et al.
Publicado: (2003)

Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model
por: Brahim Arkoun, et al.
Publicado: (2023-04-01)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
por: Tunstall-Pedoe, O, et al.
Publicado: (2008)

Natural history of GATA1 mutations in Down syndrome.
por: Ahmed, M, et al.
Publicado: (2004)

Down syndrome preleukemia and leukemia.
por: Maloney, K, et al.
Publicado: (2014)

GATA2 DEFICIENCY SYNDROME: MDS / ACUTE MYELOID LEUKEMIA IN AN ADOLESCENT PATIENT
por: Sebnem Yilmaz, et al.
Publicado: (2023-12-01)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
por: Heald, B, et al.
Publicado: (2007)

A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
por: Ana C Xavier, et al.
Publicado: (2011-01-01)

DNMT3A mutations are rare in childhood acute myeloid leukemia
por: Felicitas Thol, et al.
Publicado: (2011-08-01)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
por: Halsey, C, et al.
Publicado: (2006)

Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of <i>GATA1</i> and <i>STAG2</i> Mutations in Induced Pluripotent Stem Cells with Trisomy 21
por: Sonali P. Barwe, et al.
Publicado: (2022-02-01)

GATA1 mutational analysis in chronic myeloid leukaemia.
por: Halsey, C, et al.
Publicado: (2007)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
por: Roberts, I, et al.
Publicado: (2013)

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
por: Marius Flasinski, et al.
Publicado: (2018-07-01)

Molecular insights into Down syndrome-associated leukemia.
por: Vyas, P, et al.
Publicado: (2007)

GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
por: Li Yang, et al.
Publicado: (2017-01-01)

BCOR and BCORL1 mutations in pediatric acute myeloid leukemia
por: Jasmijn D.E. de Rooij, et al.
Publicado: (2015-05-01)

Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
por: Maximiliano Cloobs Venezia, et al.
Publicado: (2022-11-01)

Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
por: Li Yang, et al.
Publicado: (2017-01-01)

GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells
por: Koichi R. Katsumura, et al.
Publicado: (2016-08-01)

Myelodysplastic syndrome due to somatic GATA1 mutation.
por: Freson, K, et al.
Publicado: (2004)

Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with <i>GATA1</i> mutation
por: Yoko Nishinaka-Arai, et al.
Publicado: (2020-04-01)

Acute Kidney Injury in Myeloid Leukemia of Down Syndrome: Risk Factors and Outcomes
por: Chompoonut Limratchapong, et al.
Publicado: (2023-03-01)

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features
por: Marlise R. Luskin, et al.
Publicado: (2015-10-01)

The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
por: Bernhard Moser, et al.
Publicado: (2021-08-01)